Entry
Name
Th1 and Th2 cell differentiation - Homo sapiens (human)
Description
Immunity to different classes of microorganisms is orchestrated by separate lineages of effector T helper (TH)-cells, which differentiate from naive CD4+ precursor cells in response to cues provided by antigen presenting cells (APC) and include T helper type 1 (Th1) and Th2. Th1 cells are characterized by the transcription factor T-bet and signal transducer and activator of transcription (STAT) 4, and the production of IFN-gamma. These cells stimulate strong cell-mediated immune responses, particularly against intracellular pathogens. On the other hand, transcription factors like GATA-3 and STAT6 drive the generation of Th2 cells that produce IL-4, IL-5 and IL-13 and are necessary for inducing the humoral response to combat parasitic helminths (type 2 immunity) and isotype switching to IgG1 and IgE. The balance between Th1/Th2 subsets determines the susceptibility to disease states, where the improper development of Th2 cells can lead to allergy, while an overactive Th1 response can lead to autoimmunity.
Class
Organismal Systems; Immune system
BRITE hierarchy
Pathway map
hsa04658 Th1 and Th2 cell differentiation
Drug
D05092 Muromonab-CD3 (JAN/USAN/INN)
D05480 Pimecrolimus (JAN/USAN/INN)
D09033 Voclosporin (JAN/USAN/INN)
D09190 Anti-human thymocyte immunoglobulin, rabbit (JAN)
D10872 Filgotinib hydrochloride (USAN)
D10981 Rovalpituzumab tesirine (USAN/INN)
D11046 Delgocitinib (JAN/USAN/INN)
D11106 Filgotinib maleate (JAN/USAN)
D11538 Brepocitinib tosylate (USAN)
D11817 Deucravacitinib (JAN/USAN)
D11867 Deuruxolitinib phosphate (USAN)
D12212 Ivarmacitinib sulfate (USAN)
D12941 Zasocitinib (JAN/USAN/INN)
D12993 Frevecitinib (USAN/INN)
D13040 Londamocitinib (USAN/INN)
D13041 Londamocitinib xinafoate (USAN)
D13096 Tolododekin alfa (USAN)
D13123 Envudeucitinib (USAN/INN)
D13124 Envudeucitinib hydrochloride (USAN)
Other DBs
Organism
Homo sapiens (human) [GN:
hsa ]
Gene
10683 DLL3; delta-like protein 3 isoform 1 precursor [KO:K06051 ]
11317 RBPJL; recombining binding protein suppressor of hairless-like protein isoform 1 [KO:K06053 ]
1147 CHUK; inhibitor of nuclear factor kappa-B kinase subunit alpha isoform 1 [KO:K04467 ] [EC:2.7.11.10 ]
182 JAG1; protein jagged-1 precursor [KO:K06052 ]
2625 GATA3; trans-acting T-cell-specific transcription factor GATA-3 isoform 2 [KO:K17895 ]
27040 LAT; linker for activation of T-cells family member 1 isoform a [KO:K07362 ]
30009 TBX21; T-box transcription factor TBX21 [KO:K10166 ]
3108 HLA-DMA; HLA class II histocompatibility antigen, DM alpha chain precursor [KO:K06752 ]
3109 HLA-DMB; HLA class II histocompatibility antigen, DM beta chain precursor [KO:K06752 ]
3111 HLA-DOA; HLA class II histocompatibility antigen, DO alpha chain precursor [KO:K06752 ]
3112 HLA-DOB; HLA class II histocompatibility antigen, DO beta chain precursor [KO:K06752 ]
3113 HLA-DPA1; HLA class II histocompatibility antigen, DP alpha 1 chain precursor [KO:K06752 ]
3115 HLA-DPB1; HLA class II histocompatibility antigen, DP beta 1 chain precursor [KO:K06752 ]
3117 HLA-DQA1; HLA class II histocompatibility antigen, DQ alpha 1 chain precursor [KO:K06752 ]
3118 HLA-DQA2; HLA class II histocompatibility antigen, DQ alpha 2 chain precursor [KO:K06752 ]
3119 HLA-DQB1; HLA class II histocompatibility antigen, DQ beta 1 chain isoform 2 precursor [KO:K06752 ]
3120 HLA-DQB2; HLA class II histocompatibility antigen, DQ beta 2 chain isoform 2 precursor [KO:K06752 ]
3122 HLA-DRA; HLA class II histocompatibility antigen, DR alpha chain precursor [KO:K06752 ]
3123 HLA-DRB1; major histocompatibility complex, class II, DR beta 1 precursor [KO:K06752 ]
3125 HLA-DRB3; major histocompatibility complex, class II, DR beta 3 precursor [KO:K06752 ]
3126 HLA-DRB4; major histocompatibility complex, class II, DR beta 4 precursor [KO:K06752 ]
3127 HLA-DRB5; major histocompatibility complex, class II, DR beta 5 precursor [KO:K06752 ]
3459 IFNGR1; interferon gamma receptor 1 isoform 1 precursor [KO:K05132 ]
3460 IFNGR2; interferon gamma receptor 2 isoform 2 precursor [KO:K05133 ]
3516 RBPJ; recombining binding protein suppressor of hairless isoform 1 [KO:K06053 ]
3551 IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta isoform 1 [KO:K07209 ] [EC:2.7.11.10 ]
3559 IL2RA; interleukin-2 receptor subunit alpha isoform 1 precursor [KO:K05068 ]
3560 IL2RB; interleukin-2 receptor subunit beta precursor [KO:K05069 ]
3561 IL2RG; cytokine receptor common subunit gamma isoform 1 precursor [KO:K05070 ]
3565 IL4; interleukin-4 isoform 1 precursor [KO:K05430 ]
3566 IL4R; interleukin-4 receptor subunit alpha isoform a precursor [KO:K05071 ]
3592 IL12A; interleukin-12 subunit alpha isoform 4 precursor [KO:K05406 ]
3593 IL12B; interleukin-12 subunit beta precursor [KO:K05425 ]
3594 IL12RB1; interleukin-12 receptor subunit beta-1 isoform 1 precursor [KO:K05063 ]
3595 IL12RB2; interleukin-12 receptor subunit beta-2 isoform a precursor [KO:K05064 ]
3596 IL13; interleukin-13 isoform 1 precursor [KO:K05435 ]
3714 JAG2; protein jagged-2 isoform a precursor [KO:K21635 ]
4094 MAF; transcription factor Maf isoform b [KO:K09035 ]
4772 NFATC1; nuclear factor of activated T-cells, cytoplasmic 1 isoform F [KO:K04446 ]
4773 NFATC2; nuclear factor of activated T-cells, cytoplasmic 2 isoform C [KO:K17332 ]
4775 NFATC3; nuclear factor of activated T-cells, cytoplasmic 3 isoform 1 [KO:K17333 ]
4790 NFKB1; nuclear factor NF-kappa-B p105 subunit isoform 2 proprotein [KO:K02580 ]
4792 NFKBIA; NF-kappa-B inhibitor alpha [KO:K04734 ]
4793 NFKBIB; NF-kappa-B inhibitor beta isoform 1 [KO:K02581 ]
4794 NFKBIE; NF-kappa-B inhibitor epsilon [KO:K05872 ]
4851 NOTCH1; neurogenic locus notch homolog protein 1 preproprotein [KO:K02599 ]
4853 NOTCH2; neurogenic locus notch homolog protein 2 isoform 1 preproprotein [KO:K20994 ]
4854 NOTCH3; neurogenic locus notch homolog protein 3 precursor [KO:K20995 ]
5335 PLCG1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform b [KO:K01116 ] [EC:3.1.4.11 ]
5530 PPP3CA; protein phosphatase 3 catalytic subunit alpha isoform 1 [KO:K04348 ] [EC:3.1.3.16 ]
5532 PPP3CB; serine/threonine-protein phosphatase 2B catalytic subunit beta isoform isoform b [KO:K04348 ] [EC:3.1.3.16 ]
5533 PPP3CC; serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform 2 [KO:K04348 ] [EC:3.1.3.16 ]
5534 PPP3R1; calcineurin subunit B type 1 [KO:K06268 ]
5535 PPP3R2; calcineurin subunit B type 2 [KO:K06268 ]
5970 RELA; transcription factor p65 isoform 1 [KO:K04735 ]
6772 STAT1; signal transducer and activator of transcription 1-alpha/beta isoform alpha [KO:K11220 ]
6775 STAT4; signal transducer and activator of transcription 4 [KO:K11222 ]
6776 STAT5A; signal transducer and activator of transcription 5A isoform 1 [KO:K11223 ]
6777 STAT5B; signal transducer and activator of transcription 5B [KO:K11224 ]
6778 STAT6; signal transducer and activator of transcription 6 isoform 1 [KO:K11225 ]
8517 IKBKG; NF-kappa-B essential modulator isoform a [KO:K07210 ]
864 RUNX3; runt-related transcription factor 3 isoform 2 [KO:K09279 ]
915 CD3D; T-cell surface glycoprotein CD3 delta chain isoform A precursor [KO:K06450 ]
916 CD3E; T-cell surface glycoprotein CD3 epsilon chain precursor [KO:K06451 ]
917 CD3G; T-cell surface glycoprotein CD3 gamma chain precursor [KO:K06452 ]
919 CD247; T-cell surface glycoprotein CD3 zeta chain isoform 1 precursor [KO:K06453 ]
920 CD4; T-cell surface glycoprotein CD4 isoform 1 precursor [KO:K06454 ]
Compound
C01245 D-myo-Inositol 1,4,5-trisphosphate
Reference
Authors
Amsen D, Spilianakis CG, Flavell RA
Title
How are T(H)1 and T(H)2 effector cells made?
Journal
Reference
Authors
Knosp CA, Johnston JA
Title
Regulation of CD4+ T-cell polarization by suppressor of cytokine signalling proteins.
Journal
Reference
Authors
Dong C, Flavell RA
Title
Control of T helper cell differentiation--in search of master genes.
Journal
Reference
Authors
O'Garra A, Arai N
Title
The molecular basis of T helper 1 and T helper 2 cell differentiation.
Journal
Reference
Authors
Hong CC, Yao S, McCann SE, Dolnick RY, Wallace PK, Gong Z, Quan L, Lee KP, Evans SS, Repasky EA, Edge SB, Ambrosone CB
Title
Pretreatment levels of circulating Th1 and Th2 cytokines, and their ratios, are associated with ER-negative and triple negative breast cancers.
Journal
Reference
Authors
Kolls JK
Title
CD4(+) T-cell subsets and host defense in the lung.
Journal
Reference
Authors
Zhu J, Paul WE
Title
Peripheral CD4+ T-cell differentiation regulated by networks of cytokines and transcription factors.
Journal
Reference
Authors
Wilson CB, Rowell E, Sekimata M
Title
Epigenetic control of T-helper-cell differentiation.
Journal
Reference
Authors
Callard RE, Yates AJ
Title
Immunology and mathematics: crossing the divide.
Journal
Reference
Authors
Lazarevic V, Glimcher LH, Lord GM
Title
T-bet: a bridge between innate and adaptive immunity.
Journal
Reference
Authors
Weigmann B, Neurath MF
Title
T-bet and mucosal Th1 responses in the gastrointestinal tract.
Journal
Reference
Authors
Adamson AS, Collins K, Laurence A, O'Shea JJ
Title
The Current STATus of lymphocyte signaling: new roles for old players.
Journal
Reference
Authors
Zhu J
Title
Transcriptional regulation of Th2 cell differentiation.
Journal
Reference
Authors
Zhu J
Title
T helper 2 (Th2) cell differentiation, type 2 innate lymphoid cell (ILC2) development and regulation of interleukin-4 (IL-4) and IL-13 production.
Journal
Reference
Authors
Ho IC, Tai TS, Pai SY
Title
GATA3 and the T-cell lineage: essential functions before and after T-helper-2-cell differentiation.
Journal
Reference
Authors
Amsen D, Antov A, Flavell RA
Title
The different faces of Notch in T-helper-cell differentiation.
Journal
Reference
Authors
Pahan K, Mondal S
Title
Crosstalk between Nitric Oxide and T helper cells.
Journal
J Clin Cell Immunol 3:e109 (2012)
Reference
Authors
Schmidt A, Oberle N, Krammer PH
Title
Molecular mechanisms of treg-mediated T cell suppression.
Journal
Related pathway
hsa04514 Cell adhesion molecule (CAM) interaction
hsa04660 T cell receptor signaling pathway
KO pathway